Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-03139-5, published online 08 December 2021
The original version of this Article contained errors in the Results and Discussion sections, Tables 2 and 4 and in the Supplementary Information.
In the Results section, under the subheading ‘COPD and OS in patients with advanced NSCLC’,
“In the multivariate Cox proportional hazard model, TKI treatment, recurrence after curative treatment and better PS were significantly associated with better OS in patients with advanced NSCLC (Table 2).”
now reads:
“In the multivariate Cox proportional hazard model, after adjusting for clinicopathologic variables, TKI treatment, recurrence after curative treatment and better PS were significantly associated with better OS in patients with advanced NSCLC (Table 2).”
In addition, in the Results section, under the subheading ‘COPD treatment and OS’,
“The median OS in patients with COPD treatment (8.2 months) was lower than that in patients without COPD treatment (16.8 months).”
now reads:
“The median OS in patients without COPD treatment (8.2 months) was lower than that in patients with COPD treatment (16.8 months).”
In addition, in the Discussion section,
“with TKIs, infrequently diagnosed with squamous carcinoma and have a poorer PS than patients”
now reads:
“without TKIs, infrequently diagnosed without squamous carcinoma and have a poorer PS than patients”
Furthermore, the original version of this Article contained errors in Table 2 and Table 4, where “HR (95% CI)” was incorrectly given as “HRadj (95% CI)” under “Univariate”. The correct heading is as below:
Incorrect:
Variable | Univariate | |
HRadj (95% CI) | P value | |
Correct:
Variable | Univariate | |
HR (95% CI) | P value | |
The Supplementary Information file published with this Article contained an error in the Supplementary Figure 4, where under the Number of patients at risk “Without COPD treatment (n = 28)” and “With COPD treatment (n = 14)” was interchanged.
This error has now been corrected in the Supplementary Information file that accompanies the original Article.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ajimizu, H., Ozasa, H., Sato, S. et al. Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer. Sci Rep 13, 2117 (2023). https://doi.org/10.1038/s41598-023-29102-0
Published:
DOI: https://doi.org/10.1038/s41598-023-29102-0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
